Thus, these findings indicate that Chinese patients with triple-negative breast cancer display a mutation spectrum that is similar to that reported in foreign studies, and that TP53 (80%), PIK3CA (24%), PTEN (10%), and KMT2C (8%) are some of the most frequent somatic mutations. Here, PIK3CA is linked to triple-negative breast carcinoma.